グリコサミノコンドロイチンサプリメントの世界市場成長 2023-2029Global Glycosaminochondroitin Supplements Market Growth 2023-2029 LPI(エルピーアイ情報)の最新調査によると、グリコサミノコンドロイチンサプリメントの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加に伴い、グリコサミノコンドロイチンサプリ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(エルピーアイ情報)の最新調査によると、グリコサミノコンドロイチンサプリメントの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加に伴い、グリコサミノコンドロイチンサプリメントは、レビュー期間中の年平均成長率(CAGR)%で2029年までに百万米ドルの再調整規模になると予測されています。この調査レポートは、世界のグリコサミノコンドロイチンサプリメント市場の成長の可能性を明らかにします。グリコサミノコンドロイチンサプリメントは今後の市場でも安定した成長が期待される。しかし、グリコサミノコンドロイチンサプリメントの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、グリコサミノコンドロイチン・サプリメント市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要がある。 世界的な高齢化が、グリコサミノグリカン・サプリメントを含む関節健康サプリメントの需要を促進している。高齢化が進むと、変形性関節症など関節に関連する問題が発生しやすくなる。関節の健康と予防医療の重要性に対する認識が高まり、グルコサミンやコンドロイチンのようなサプリメントを求める消費者が増えている。電子商取引の台頭により、消費者はGAGサプリメントを含む様々な栄養補助食品に容易にアクセスできるようになり、市場の成長に寄与している。 主な特徴 グリコサミノコンドロイチンサプリメント市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、グリコサミノコンドロイチンサプリメント市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(カプセル、タブレットなど)、地域別内訳を含む場合があります。 市場の促進要因と課題:政府規制、環境問題、技術進歩、消費者の嗜好の変化など、グリコサミノコンドロイチンサプリメント市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。 競合情勢:この調査レポートは、グリコサミノコンドロイチンサプリメント市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。 技術開発:調査レポートは、グリコサミノコンドロイチンサプリメント業界における最新の技術開発を掘り下げることができます。これには、グリコサミノコンドロイチンサプリメント技術の進歩、グリコサミノコンドロイチンサプリメントの新規参入企業、グリコサミノコンドロイチンサプリメントの新規投資、グリコサミノコンドロイチンサプリメントの将来を形作るその他の技術革新が含まれます。 川下企業の好み:このレポートは、グリコサミノコンドロイチンサプリメント市場における顧客の購買行動と採用傾向に光を当てることができます。顧客の購買決定、グリコサミノコンドロイチンサプリメント製品の嗜好に影響を与える要因も含まれる。 政府の政策とインセンティブ:調査レポートは、政府の政策とインセンティブがグリコサミノコンドロイチンサプリメント市場に与える影響を分析します。これには、グリコサミノコンドロイチンサプリメント市場の促進を目的とした規制枠組み、補助金、税制優遇措置、その他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価する。 環境への影響と持続可能性調査レポートは、グリコサミノコンドロイチンサプリメント市場の環境への影響と持続可能性の側面を評価します。 市場予測と将来展望:実施した分析に基づき、調査レポートはグリコサミノコンドロイチンサプリメント産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、グリコサミノコンドロイチンサプリメント市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 グリコサミノコンドロイチンサプリメント市場は、タイプ別と用途別に分けられます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント カプセル 錠剤 その他 用途別セグメント 薬局 スーパーマーケット その他 本レポートは地域別にも市場を分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 サントリー オリヒログループ アンシン ワントゥミン・バイオロジカル TSIグループ 煙台東城 フォーカスケム YBCC 倫新生物技術 ISBA 匯文 QJBCHINA メイテック(シヌトラ・インターナショナル) 恒傑生物製薬 日本臓器 GGI サミットニュートリショナルズ スーファーマ 瑞康大生化学 広隆生物化学 パシフィックレインボー サミット ニュートリショナルズ インターナショナル ウェバーナチュラルズ マニングス ライフエクステンション シフ ドクターズベスト オステオバイオフレックス カークランド 本レポートで扱う主な質問 世界のグリコサミノコンドロイチンサプリメント市場の10年展望は? グリコサミノコンドロイチンサプリメントの世界市場および地域別市場成長の要因は何か? 市場別、地域別に最も急成長する技術は何か? グリコサミノコンドロイチンサプリメントの市場機会は最終市場規模によってどのように異なるのか? グリコサミノコンドロイチンサプリメントのタイプ別、用途別内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Glycosaminochondroitin Supplements Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Glycosaminochondroitin Supplements by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Glycosaminochondroitin Supplements by Country/Region, 2018, 2022 & 2029 2.2 Glycosaminochondroitin Supplements Segment by Type 2.2.1 Capsule 2.2.2 Tablet 2.2.3 Others 2.3 Glycosaminochondroitin Supplements Sales by Type 2.3.1 Global Glycosaminochondroitin Supplements Sales Market Share by Type (2018-2023) 2.3.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Type (2018-2023) 2.3.3 Global Glycosaminochondroitin Supplements Sale Price by Type (2018-2023) 2.4 Glycosaminochondroitin Supplements Segment by Application 2.4.1 Pharmacy 2.4.2 Supermarket 2.4.3 Others 2.5 Glycosaminochondroitin Supplements Sales by Application 2.5.1 Global Glycosaminochondroitin Supplements Sale Market Share by Application (2018-2023) 2.5.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Application (2018-2023) 2.5.3 Global Glycosaminochondroitin Supplements Sale Price by Application (2018-2023) 3 Global Glycosaminochondroitin Supplements by Company 3.1 Global Glycosaminochondroitin Supplements Breakdown Data by Company 3.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Company (2018-2023) 3.1.2 Global Glycosaminochondroitin Supplements Sales Market Share by Company (2018-2023) 3.2 Global Glycosaminochondroitin Supplements Annual Revenue by Company (2018-2023) 3.2.1 Global Glycosaminochondroitin Supplements Revenue by Company (2018-2023) 3.2.2 Global Glycosaminochondroitin Supplements Revenue Market Share by Company (2018-2023) 3.3 Global Glycosaminochondroitin Supplements Sale Price by Company 3.4 Key Manufacturers Glycosaminochondroitin Supplements Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Glycosaminochondroitin Supplements Product Location Distribution 3.4.2 Players Glycosaminochondroitin Supplements Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Glycosaminochondroitin Supplements by Geographic Region 4.1 World Historic Glycosaminochondroitin Supplements Market Size by Geographic Region (2018-2023) 4.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Glycosaminochondroitin Supplements Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Glycosaminochondroitin Supplements Market Size by Country/Region (2018-2023) 4.2.1 Global Glycosaminochondroitin Supplements Annual Sales by Country/Region (2018-2023) 4.2.2 Global Glycosaminochondroitin Supplements Annual Revenue by Country/Region (2018-2023) 4.3 Americas Glycosaminochondroitin Supplements Sales Growth 4.4 APAC Glycosaminochondroitin Supplements Sales Growth 4.5 Europe Glycosaminochondroitin Supplements Sales Growth 4.6 Middle East & Africa Glycosaminochondroitin Supplements Sales Growth 5 Americas 5.1 Americas Glycosaminochondroitin Supplements Sales by Country 5.1.1 Americas Glycosaminochondroitin Supplements Sales by Country (2018-2023) 5.1.2 Americas Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 5.2 Americas Glycosaminochondroitin Supplements Sales by Type 5.3 Americas Glycosaminochondroitin Supplements Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Glycosaminochondroitin Supplements Sales by Region 6.1.1 APAC Glycosaminochondroitin Supplements Sales by Region (2018-2023) 6.1.2 APAC Glycosaminochondroitin Supplements Revenue by Region (2018-2023) 6.2 APAC Glycosaminochondroitin Supplements Sales by Type 6.3 APAC Glycosaminochondroitin Supplements Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Glycosaminochondroitin Supplements by Country 7.1.1 Europe Glycosaminochondroitin Supplements Sales by Country (2018-2023) 7.1.2 Europe Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 7.2 Europe Glycosaminochondroitin Supplements Sales by Type 7.3 Europe Glycosaminochondroitin Supplements Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Glycosaminochondroitin Supplements by Country 8.1.1 Middle East & Africa Glycosaminochondroitin Supplements Sales by Country (2018-2023) 8.1.2 Middle East & Africa Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 8.2 Middle East & Africa Glycosaminochondroitin Supplements Sales by Type 8.3 Middle East & Africa Glycosaminochondroitin Supplements Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Glycosaminochondroitin Supplements 10.3 Manufacturing Process Analysis of Glycosaminochondroitin Supplements 10.4 Industry Chain Structure of Glycosaminochondroitin Supplements 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Glycosaminochondroitin Supplements Distributors 11.3 Glycosaminochondroitin Supplements Customer 12 World Forecast Review for Glycosaminochondroitin Supplements by Geographic Region 12.1 Global Glycosaminochondroitin Supplements Market Size Forecast by Region 12.1.1 Global Glycosaminochondroitin Supplements Forecast by Region (2024-2029) 12.1.2 Global Glycosaminochondroitin Supplements Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Glycosaminochondroitin Supplements Forecast by Type 12.7 Global Glycosaminochondroitin Supplements Forecast by Application 13 Key Players Analysis 13.1 Suntory 13.1.1 Suntory Company Information 13.1.2 Suntory Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.1.3 Suntory Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Suntory Main Business Overview 13.1.5 Suntory Latest Developments 13.2 Orihiro Group 13.2.1 Orihiro Group Company Information 13.2.2 Orihiro Group Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.2.3 Orihiro Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Orihiro Group Main Business Overview 13.2.5 Orihiro Group Latest Developments 13.3 ANXIN 13.3.1 ANXIN Company Information 13.3.2 ANXIN Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.3.3 ANXIN Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ANXIN Main Business Overview 13.3.5 ANXIN Latest Developments 13.4 WanTuMing Biological 13.4.1 WanTuMing Biological Company Information 13.4.2 WanTuMing Biological Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.4.3 WanTuMing Biological Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 WanTuMing Biological Main Business Overview 13.4.5 WanTuMing Biological Latest Developments 13.5 TSI Group 13.5.1 TSI Group Company Information 13.5.2 TSI Group Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.5.3 TSI Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 TSI Group Main Business Overview 13.5.5 TSI Group Latest Developments 13.6 Yantai Dongcheng 13.6.1 Yantai Dongcheng Company Information 13.6.2 Yantai Dongcheng Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.6.3 Yantai Dongcheng Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Yantai Dongcheng Main Business Overview 13.6.5 Yantai Dongcheng Latest Developments 13.7 Focus Chem 13.7.1 Focus Chem Company Information 13.7.2 Focus Chem Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.7.3 Focus Chem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Focus Chem Main Business Overview 13.7.5 Focus Chem Latest Developments 13.8 YBCC 13.8.1 YBCC Company Information 13.8.2 YBCC Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.8.3 YBCC Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 YBCC Main Business Overview 13.8.5 YBCC Latest Developments 13.9 Runxin Biotechnology 13.9.1 Runxin Biotechnology Company Information 13.9.2 Runxin Biotechnology Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.9.3 Runxin Biotechnology Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Runxin Biotechnology Main Business Overview 13.9.5 Runxin Biotechnology Latest Developments 13.10 ISBA 13.10.1 ISBA Company Information 13.10.2 ISBA Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.10.3 ISBA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 ISBA Main Business Overview 13.10.5 ISBA Latest Developments 13.11 Huiwen 13.11.1 Huiwen Company Information 13.11.2 Huiwen Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.11.3 Huiwen Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Huiwen Main Business Overview 13.11.5 Huiwen Latest Developments 13.12 QJBCHINA 13.12.1 QJBCHINA Company Information 13.12.2 QJBCHINA Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.12.3 QJBCHINA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 QJBCHINA Main Business Overview 13.12.5 QJBCHINA Latest Developments 13.13 Meitek(Synutra International) 13.13.1 Meitek(Synutra International) Company Information 13.13.2 Meitek(Synutra International) Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.13.3 Meitek(Synutra International) Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Meitek(Synutra International) Main Business Overview 13.13.5 Meitek(Synutra International) Latest Developments 13.14 Hengjie Bio-Pharmaceuticals 13.14.1 Hengjie Bio-Pharmaceuticals Company Information 13.14.2 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.14.3 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Hengjie Bio-Pharmaceuticals Main Business Overview 13.14.5 Hengjie Bio-Pharmaceuticals Latest Developments 13.15 Nippon Zoki 13.15.1 Nippon Zoki Company Information 13.15.2 Nippon Zoki Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.15.3 Nippon Zoki Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Nippon Zoki Main Business Overview 13.15.5 Nippon Zoki Latest Developments 13.16 GGI 13.16.1 GGI Company Information 13.16.2 GGI Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.16.3 GGI Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 GGI Main Business Overview 13.16.5 GGI Latest Developments 13.17 Summit Nutritionals 13.17.1 Summit Nutritionals Company Information 13.17.2 Summit Nutritionals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.17.3 Summit Nutritionals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Summit Nutritionals Main Business Overview 13.17.5 Summit Nutritionals Latest Developments 13.18 Sioux Pharm 13.18.1 Sioux Pharm Company Information 13.18.2 Sioux Pharm Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.18.3 Sioux Pharm Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 Sioux Pharm Main Business Overview 13.18.5 Sioux Pharm Latest Developments 13.19 Ruikangda Biochemical 13.19.1 Ruikangda Biochemical Company Information 13.19.2 Ruikangda Biochemical Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.19.3 Ruikangda Biochemical Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Ruikangda Biochemical Main Business Overview 13.19.5 Ruikangda Biochemical Latest Developments 13.20 Guanglong Biochem 13.20.1 Guanglong Biochem Company Information 13.20.2 Guanglong Biochem Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.20.3 Guanglong Biochem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Guanglong Biochem Main Business Overview 13.20.5 Guanglong Biochem Latest Developments 13.21 Pacific Rainbow 13.21.1 Pacific Rainbow Company Information 13.21.2 Pacific Rainbow Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.21.3 Pacific Rainbow Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Pacific Rainbow Main Business Overview 13.21.5 Pacific Rainbow Latest Developments 13.22 Summit Nutritionals International 13.22.1 Summit Nutritionals International Company Information 13.22.2 Summit Nutritionals International Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.22.3 Summit Nutritionals International Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Summit Nutritionals International Main Business Overview 13.22.5 Summit Nutritionals International Latest Developments 13.23 Webber Naturals 13.23.1 Webber Naturals Company Information 13.23.2 Webber Naturals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.23.3 Webber Naturals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.23.4 Webber Naturals Main Business Overview 13.23.5 Webber Naturals Latest Developments 13.24 Mannings 13.24.1 Mannings Company Information 13.24.2 Mannings Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.24.3 Mannings Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.24.4 Mannings Main Business Overview 13.24.5 Mannings Latest Developments 13.25 Life Extension 13.25.1 Life Extension Company Information 13.25.2 Life Extension Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.25.3 Life Extension Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.25.4 Life Extension Main Business Overview 13.25.5 Life Extension Latest Developments 13.26 Schiff 13.26.1 Schiff Company Information 13.26.2 Schiff Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.26.3 Schiff Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.26.4 Schiff Main Business Overview 13.26.5 Schiff Latest Developments 13.27 Doctor's Best 13.27.1 Doctor's Best Company Information 13.27.2 Doctor's Best Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.27.3 Doctor's Best Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.27.4 Doctor's Best Main Business Overview 13.27.5 Doctor's Best Latest Developments 13.28 Osteo Bi-Flex 13.28.1 Osteo Bi-Flex Company Information 13.28.2 Osteo Bi-Flex Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.28.3 Osteo Bi-Flex Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.28.4 Osteo Bi-Flex Main Business Overview 13.28.5 Osteo Bi-Flex Latest Developments 13.29 Kirkland 13.29.1 Kirkland Company Information 13.29.2 Kirkland Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.29.3 Kirkland Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.29.4 Kirkland Main Business Overview 13.29.5 Kirkland Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Glycosaminochondroitin Supplements market size was valued at US$ million in 2022. With growing demand in downstream market, the Glycosaminochondroitin Supplements is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Glycosaminochondroitin Supplements Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Glycosaminochondroitin Supplements by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Glycosaminochondroitin Supplements by Country/Region, 2018, 2022 & 2029 2.2 Glycosaminochondroitin Supplements Segment by Type 2.2.1 Capsule 2.2.2 Tablet 2.2.3 Others 2.3 Glycosaminochondroitin Supplements Sales by Type 2.3.1 Global Glycosaminochondroitin Supplements Sales Market Share by Type (2018-2023) 2.3.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Type (2018-2023) 2.3.3 Global Glycosaminochondroitin Supplements Sale Price by Type (2018-2023) 2.4 Glycosaminochondroitin Supplements Segment by Application 2.4.1 Pharmacy 2.4.2 Supermarket 2.4.3 Others 2.5 Glycosaminochondroitin Supplements Sales by Application 2.5.1 Global Glycosaminochondroitin Supplements Sale Market Share by Application (2018-2023) 2.5.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Application (2018-2023) 2.5.3 Global Glycosaminochondroitin Supplements Sale Price by Application (2018-2023) 3 Global Glycosaminochondroitin Supplements by Company 3.1 Global Glycosaminochondroitin Supplements Breakdown Data by Company 3.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Company (2018-2023) 3.1.2 Global Glycosaminochondroitin Supplements Sales Market Share by Company (2018-2023) 3.2 Global Glycosaminochondroitin Supplements Annual Revenue by Company (2018-2023) 3.2.1 Global Glycosaminochondroitin Supplements Revenue by Company (2018-2023) 3.2.2 Global Glycosaminochondroitin Supplements Revenue Market Share by Company (2018-2023) 3.3 Global Glycosaminochondroitin Supplements Sale Price by Company 3.4 Key Manufacturers Glycosaminochondroitin Supplements Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Glycosaminochondroitin Supplements Product Location Distribution 3.4.2 Players Glycosaminochondroitin Supplements Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Glycosaminochondroitin Supplements by Geographic Region 4.1 World Historic Glycosaminochondroitin Supplements Market Size by Geographic Region (2018-2023) 4.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Glycosaminochondroitin Supplements Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Glycosaminochondroitin Supplements Market Size by Country/Region (2018-2023) 4.2.1 Global Glycosaminochondroitin Supplements Annual Sales by Country/Region (2018-2023) 4.2.2 Global Glycosaminochondroitin Supplements Annual Revenue by Country/Region (2018-2023) 4.3 Americas Glycosaminochondroitin Supplements Sales Growth 4.4 APAC Glycosaminochondroitin Supplements Sales Growth 4.5 Europe Glycosaminochondroitin Supplements Sales Growth 4.6 Middle East & Africa Glycosaminochondroitin Supplements Sales Growth 5 Americas 5.1 Americas Glycosaminochondroitin Supplements Sales by Country 5.1.1 Americas Glycosaminochondroitin Supplements Sales by Country (2018-2023) 5.1.2 Americas Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 5.2 Americas Glycosaminochondroitin Supplements Sales by Type 5.3 Americas Glycosaminochondroitin Supplements Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Glycosaminochondroitin Supplements Sales by Region 6.1.1 APAC Glycosaminochondroitin Supplements Sales by Region (2018-2023) 6.1.2 APAC Glycosaminochondroitin Supplements Revenue by Region (2018-2023) 6.2 APAC Glycosaminochondroitin Supplements Sales by Type 6.3 APAC Glycosaminochondroitin Supplements Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Glycosaminochondroitin Supplements by Country 7.1.1 Europe Glycosaminochondroitin Supplements Sales by Country (2018-2023) 7.1.2 Europe Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 7.2 Europe Glycosaminochondroitin Supplements Sales by Type 7.3 Europe Glycosaminochondroitin Supplements Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Glycosaminochondroitin Supplements by Country 8.1.1 Middle East & Africa Glycosaminochondroitin Supplements Sales by Country (2018-2023) 8.1.2 Middle East & Africa Glycosaminochondroitin Supplements Revenue by Country (2018-2023) 8.2 Middle East & Africa Glycosaminochondroitin Supplements Sales by Type 8.3 Middle East & Africa Glycosaminochondroitin Supplements Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Glycosaminochondroitin Supplements 10.3 Manufacturing Process Analysis of Glycosaminochondroitin Supplements 10.4 Industry Chain Structure of Glycosaminochondroitin Supplements 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Glycosaminochondroitin Supplements Distributors 11.3 Glycosaminochondroitin Supplements Customer 12 World Forecast Review for Glycosaminochondroitin Supplements by Geographic Region 12.1 Global Glycosaminochondroitin Supplements Market Size Forecast by Region 12.1.1 Global Glycosaminochondroitin Supplements Forecast by Region (2024-2029) 12.1.2 Global Glycosaminochondroitin Supplements Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Glycosaminochondroitin Supplements Forecast by Type 12.7 Global Glycosaminochondroitin Supplements Forecast by Application 13 Key Players Analysis 13.1 Suntory 13.1.1 Suntory Company Information 13.1.2 Suntory Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.1.3 Suntory Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Suntory Main Business Overview 13.1.5 Suntory Latest Developments 13.2 Orihiro Group 13.2.1 Orihiro Group Company Information 13.2.2 Orihiro Group Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.2.3 Orihiro Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Orihiro Group Main Business Overview 13.2.5 Orihiro Group Latest Developments 13.3 ANXIN 13.3.1 ANXIN Company Information 13.3.2 ANXIN Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.3.3 ANXIN Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ANXIN Main Business Overview 13.3.5 ANXIN Latest Developments 13.4 WanTuMing Biological 13.4.1 WanTuMing Biological Company Information 13.4.2 WanTuMing Biological Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.4.3 WanTuMing Biological Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 WanTuMing Biological Main Business Overview 13.4.5 WanTuMing Biological Latest Developments 13.5 TSI Group 13.5.1 TSI Group Company Information 13.5.2 TSI Group Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.5.3 TSI Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 TSI Group Main Business Overview 13.5.5 TSI Group Latest Developments 13.6 Yantai Dongcheng 13.6.1 Yantai Dongcheng Company Information 13.6.2 Yantai Dongcheng Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.6.3 Yantai Dongcheng Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Yantai Dongcheng Main Business Overview 13.6.5 Yantai Dongcheng Latest Developments 13.7 Focus Chem 13.7.1 Focus Chem Company Information 13.7.2 Focus Chem Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.7.3 Focus Chem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Focus Chem Main Business Overview 13.7.5 Focus Chem Latest Developments 13.8 YBCC 13.8.1 YBCC Company Information 13.8.2 YBCC Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.8.3 YBCC Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 YBCC Main Business Overview 13.8.5 YBCC Latest Developments 13.9 Runxin Biotechnology 13.9.1 Runxin Biotechnology Company Information 13.9.2 Runxin Biotechnology Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.9.3 Runxin Biotechnology Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Runxin Biotechnology Main Business Overview 13.9.5 Runxin Biotechnology Latest Developments 13.10 ISBA 13.10.1 ISBA Company Information 13.10.2 ISBA Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.10.3 ISBA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 ISBA Main Business Overview 13.10.5 ISBA Latest Developments 13.11 Huiwen 13.11.1 Huiwen Company Information 13.11.2 Huiwen Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.11.3 Huiwen Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Huiwen Main Business Overview 13.11.5 Huiwen Latest Developments 13.12 QJBCHINA 13.12.1 QJBCHINA Company Information 13.12.2 QJBCHINA Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.12.3 QJBCHINA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 QJBCHINA Main Business Overview 13.12.5 QJBCHINA Latest Developments 13.13 Meitek(Synutra International) 13.13.1 Meitek(Synutra International) Company Information 13.13.2 Meitek(Synutra International) Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.13.3 Meitek(Synutra International) Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Meitek(Synutra International) Main Business Overview 13.13.5 Meitek(Synutra International) Latest Developments 13.14 Hengjie Bio-Pharmaceuticals 13.14.1 Hengjie Bio-Pharmaceuticals Company Information 13.14.2 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.14.3 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Hengjie Bio-Pharmaceuticals Main Business Overview 13.14.5 Hengjie Bio-Pharmaceuticals Latest Developments 13.15 Nippon Zoki 13.15.1 Nippon Zoki Company Information 13.15.2 Nippon Zoki Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.15.3 Nippon Zoki Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Nippon Zoki Main Business Overview 13.15.5 Nippon Zoki Latest Developments 13.16 GGI 13.16.1 GGI Company Information 13.16.2 GGI Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.16.3 GGI Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 GGI Main Business Overview 13.16.5 GGI Latest Developments 13.17 Summit Nutritionals 13.17.1 Summit Nutritionals Company Information 13.17.2 Summit Nutritionals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.17.3 Summit Nutritionals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Summit Nutritionals Main Business Overview 13.17.5 Summit Nutritionals Latest Developments 13.18 Sioux Pharm 13.18.1 Sioux Pharm Company Information 13.18.2 Sioux Pharm Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.18.3 Sioux Pharm Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 Sioux Pharm Main Business Overview 13.18.5 Sioux Pharm Latest Developments 13.19 Ruikangda Biochemical 13.19.1 Ruikangda Biochemical Company Information 13.19.2 Ruikangda Biochemical Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.19.3 Ruikangda Biochemical Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Ruikangda Biochemical Main Business Overview 13.19.5 Ruikangda Biochemical Latest Developments 13.20 Guanglong Biochem 13.20.1 Guanglong Biochem Company Information 13.20.2 Guanglong Biochem Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.20.3 Guanglong Biochem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Guanglong Biochem Main Business Overview 13.20.5 Guanglong Biochem Latest Developments 13.21 Pacific Rainbow 13.21.1 Pacific Rainbow Company Information 13.21.2 Pacific Rainbow Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.21.3 Pacific Rainbow Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Pacific Rainbow Main Business Overview 13.21.5 Pacific Rainbow Latest Developments 13.22 Summit Nutritionals International 13.22.1 Summit Nutritionals International Company Information 13.22.2 Summit Nutritionals International Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.22.3 Summit Nutritionals International Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Summit Nutritionals International Main Business Overview 13.22.5 Summit Nutritionals International Latest Developments 13.23 Webber Naturals 13.23.1 Webber Naturals Company Information 13.23.2 Webber Naturals Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.23.3 Webber Naturals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.23.4 Webber Naturals Main Business Overview 13.23.5 Webber Naturals Latest Developments 13.24 Mannings 13.24.1 Mannings Company Information 13.24.2 Mannings Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.24.3 Mannings Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.24.4 Mannings Main Business Overview 13.24.5 Mannings Latest Developments 13.25 Life Extension 13.25.1 Life Extension Company Information 13.25.2 Life Extension Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.25.3 Life Extension Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.25.4 Life Extension Main Business Overview 13.25.5 Life Extension Latest Developments 13.26 Schiff 13.26.1 Schiff Company Information 13.26.2 Schiff Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.26.3 Schiff Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.26.4 Schiff Main Business Overview 13.26.5 Schiff Latest Developments 13.27 Doctor's Best 13.27.1 Doctor's Best Company Information 13.27.2 Doctor's Best Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.27.3 Doctor's Best Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.27.4 Doctor's Best Main Business Overview 13.27.5 Doctor's Best Latest Developments 13.28 Osteo Bi-Flex 13.28.1 Osteo Bi-Flex Company Information 13.28.2 Osteo Bi-Flex Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.28.3 Osteo Bi-Flex Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.28.4 Osteo Bi-Flex Main Business Overview 13.28.5 Osteo Bi-Flex Latest Developments 13.29 Kirkland 13.29.1 Kirkland Company Information 13.29.2 Kirkland Glycosaminochondroitin Supplements Product Portfolios and Specifications 13.29.3 Kirkland Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023) 13.29.4 Kirkland Main Business Overview 13.29.5 Kirkland Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
LP Information 社の最新刊レポート本レポートと同じKEY WORD(supplements)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/06 10:26 144.24 円 160.68 円 192.83 円 |